Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]
SEC Accession No. 0001213900-25-018981
Filing Date
2025-03-03
Accepted
2025-03-03 06:40:12
Documents
131

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0226019-02.htm   iXBRL F-4/A 23216384
2 FORM OF PRE-FUNDED WARRANT ea022601902ex4-1_nlspharma.htm EX-4.1 82933
3 FORM OF CONTINGENT VALUE RIGHT AGREEMENT, BY AND BETWEEN NLS PHARMACEUTICS LTD. ea022601902ex4-2_nlspharma.htm EX-4.2 103373
4 OPINION OF BAKER MCKENZIE SWITZERLAND LTD. REGARDING CERTAIN SWISS TAX MATTERS ea022601902ex8-1_nlspharma.htm EX-8.1 28261
5 FEASIBILITY STUDY AGREEMENT, DATED SEPTEMBER 9, 2018, BY AND AMONG KADIMASTEM LT ea022601902ex10-7_nlspharma.htm EX-10.7 141289
6 RESEARCH AND LICENSE AGREEMENT, DATED JANUARY 22, 2015, BY AND BETWEEN THE RAMOT ea022601902ex10-8_nlspharma.htm EX-10.8 341660
7 COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT, DATED APRIL 29, 2023, BETWEEN ea022601902ex10-9_nlspharma.htm EX-10.9 121266
8 AMENDED AND RESTATED RESEARCH AND LICENSE AGREEMENT, DATED MAY 7, 2013, BETWEEN ea022601902ex10-10_nlspharma.htm EX-10.10 253527
9 FORM OF INDEMNIFICATION AGREEMENT ea022601902ex10-11_nlspharma.htm EX-10.11 24370
10 CONSENT OF PRICEWATERHOUSECOOPERS AG ea022601902ex23-1_nlspharma.htm EX-23.1 1802
11 KOST FORER GABBAY KASIERER ea022601902ex23-3_nlspharma.htm EX-23.3 4246
12 CONSENT OF PROF. MICHEL REVEL AS DIRECTOR NOMINEE ea022601902ex99-4_nlspharma.htm EX-99.4 2758
13 CONSENT OF ERAN IOHAN AS DIRECTOR NOMINEE ea022601902ex99-5_nlspharma.htm EX-99.5 2942
14 CONSENT OF LIORA OREN AS DIRECTOR NOMINEE ea022601902ex99-6_nlspharma.htm EX-99.6 2865
15 CONSENT OF TAMMY GALILI AS DIRECTOR NOMINEE ea022601902ex99-7_nlspharma.htm EX-99.7 2800
16 CONSENT OF RONEN TWITO AS DIRECTOR NOMINEE ea022601902ex99-8_nlspharma.htm EX-99.8 2868
22 GRAPHIC ex23-3_001.jpg GRAPHIC 2149
23 GRAPHIC ex8-1_001.jpg GRAPHIC 7029
24 GRAPHIC ex8-1_002.jpg GRAPHIC 3767
25 GRAPHIC tbarchart_001.jpg GRAPHIC 240459
26 GRAPHIC tbarchart_010.jpg GRAPHIC 161315
27 GRAPHIC tcover_001.jpg GRAPHIC 1952554
28 GRAPHIC tcover_002.jpg GRAPHIC 1968254
29 GRAPHIC timage_001.jpg GRAPHIC 496447
30 GRAPHIC timage_002.jpg GRAPHIC 108709
31 GRAPHIC timage_004.jpg GRAPHIC 757600
32 GRAPHIC timage_005.jpg GRAPHIC 114225
33 GRAPHIC timage_006.jpg GRAPHIC 469882
34 GRAPHIC timage_007.jpg GRAPHIC 515097
35 GRAPHIC timage_008.jpg GRAPHIC 462442
36 GRAPHIC timage_009.jpg GRAPHIC 379707
37 GRAPHIC timage_011.jpg GRAPHIC 931655
38 GRAPHIC timage_012.jpg GRAPHIC 95427
39 GRAPHIC timage_013.jpg GRAPHIC 78305
40 GRAPHIC timage_014.jpg GRAPHIC 352499
41 GRAPHIC timage_015.jpg GRAPHIC 594589
42 GRAPHIC timage_016.jpg GRAPHIC 322610
43 GRAPHIC timage_017.jpg GRAPHIC 296596
44 GRAPHIC timage_018.jpg GRAPHIC 310984
45 GRAPHIC timage_019.jpg GRAPHIC 412892
46 GRAPHIC timage_020.jpg GRAPHIC 368677
47 GRAPHIC timage_022.jpg GRAPHIC 309990
48 GRAPHIC timage_023.jpg GRAPHIC 441369
49 GRAPHIC timage_024.jpg GRAPHIC 86503
50 GRAPHIC timage_025.jpg GRAPHIC 63953
51 GRAPHIC timage_026.jpg GRAPHIC 80217
52 GRAPHIC timage_027.jpg GRAPHIC 473560
53 GRAPHIC timage_028.jpg GRAPHIC 347255
54 GRAPHIC tlinechart_001.jpg GRAPHIC 255094
55 GRAPHIC tlinechart_002.jpg GRAPHIC 238760
56 GRAPHIC tlinechart_003.jpg GRAPHIC 236343
57 GRAPHIC tlinechart_004.jpg GRAPHIC 343981
58 GRAPHIC tmap_001.jpg GRAPHIC 1003310
59 GRAPHIC tmoorefooter_logo.jpg GRAPHIC 28694
60 GRAPHIC tmoorefooter_logo1.jpg GRAPHIC 28702
61 GRAPHIC tmoorefooter_logo2.jpg GRAPHIC 28706
62 GRAPHIC tmoorefooter_logo3.jpg GRAPHIC 28709
63 GRAPHIC tnls_logo.jpg GRAPHIC 46506
64 GRAPHIC tpiechart_001.jpg GRAPHIC 258932
65 GRAPHIC tproxy_001.jpg GRAPHIC 1261476
66 GRAPHIC tproxy_002.jpg GRAPHIC 1528760
67 GRAPHIC tproxy_003.jpg GRAPHIC 1205907
68 GRAPHIC tsign_moore.jpg GRAPHIC 21862
  Complete submission text file 0001213900-25-018981.txt   80985774

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE nlsp-20231231.xsd EX-101.SCH 51898
18 XBRL CALCULATION FILE nlsp-20231231_cal.xml EX-101.CAL 50117
19 XBRL DEFINITION FILE nlsp-20231231_def.xml EX-101.DEF 268283
20 XBRL LABEL FILE nlsp-20231231_lab.xml EX-101.LAB 525598
21 XBRL PRESENTATION FILE nlsp-20231231_pre.xml EX-101.PRE 292583
135 EXTRACTED XBRL INSTANCE DOCUMENT ea0226019-02_htm.xml XML 1641146
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-4/A | Act: 33 | File No.: 333-284075 | Film No.: 25693690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)